Clinical Trial in Patients With Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT00081627

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00081627. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.

Study identification

NCT ID: NCT00081627
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Mast Therapeutics, Inc.; Industry
Enrollment: 48 participants

Conditions and interventions

Conditions

Interventions

CoFactor and 5FU Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Apr 2004 (Type not available)
Primary completion: Not listed
Completion: Jan 2007 (Actual)
Last update posted: Nov 27, 2007

2004 – 2007

United States locations

U.S. sites: 5
U.S. states: 3
U.S. cities: 5

Facility	City	State	ZIP	Site status
UCSD Moores Cancer Center	La Jolla	California	92037	—
Mercy General Hospital	Sacramento	California	95819	—
VA San Diego Healthcare System	San Diego	California	92161	—
Spectrum Health	Grand Rapids	Michigan	49503	—
Killeen Cancer Center	Killeen	Texas	76549	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00081627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 27, 2007 · Synced Nov 15, 2026